KNG1 and COVID-19: Thus, less des-Arg9-BK inactivation combined with its longer systemic blood half-life (Cyr et al., 2001; Jackson et al., 2021) might partially explain the higher circulating levels of des-Arg9-BK in COVID-19 patients.